bluebird bio, Inc.
BLUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $83,807 | $29,497 | $3,597 | $3,662 |
| % Growth | 184.1% | 720% | -1.8% | – |
| Cost of Goods Sold | $89,380 | $33,527 | $10,077 | $38,857 |
| Gross Profit | -$5,573 | -$4,030 | -$6,480 | -$35,195 |
| % Margin | -6.6% | -13.7% | -180.2% | -961.1% |
| R&D Expenses | $94,252 | $167,652 | $240,764 | $319,946 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $167,874 | $165,510 | $136,908 | $209,969 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,762 | -$92,930 | -$133,967 | $25,801 |
| Operating Expenses | $264,888 | $240,232 | $243,705 | $555,716 |
| Operating Income | -$270,461 | -$244,262 | -$250,185 | -$590,911 |
| % Margin | -322.7% | -828.1% | -6,955.4% | -16,136.3% |
| Other Income/Exp. Net | $29,816 | $32,223 | $19,960 | $28,531 |
| Pre-Tax Income | -$240,645 | -$212,039 | -$230,225 | -$562,380 |
| Tax Expense | $70 | -$126 | $117 | $258 |
| Net Income | -$240,715 | -$211,913 | -$230,342 | -$819,378 |
| % Margin | -287.2% | -718.4% | -6,403.7% | -22,375.2% |
| EPS | -24.84 | -2.97 | -3.39 | -8.16 |
| % Growth | -736.4% | 12.4% | 58.5% | – |
| EPS Diluted | -24.84 | -2.97 | -3.39 | -8.16 |
| Weighted Avg Shares Out | 9,689 | 71,347 | 78,585 | 68,910 |
| Weighted Avg Shares Out Dil | 9,689 | 71,347 | 78,585 | 68,910 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8,218 | $9,869 | $1,032 | $879 |
| Interest Expense | $22,579 | $16,353 | $6,322 | $0 |
| Depreciation & Amortization | $61,244 | $28,525 | $8,344 | $5,454 |
| EBITDA | -$156,822 | -$167,161 | -$215,559 | -$556,926 |
| % Margin | -187.1% | -566.7% | -5,992.7% | -15,208.2% |